Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementiaMIELKE, R; KITTNER, B; GHAEMI, M et al.Journal of the neurological sciences. 1996, Vol 141, Num 1-2, pp 59-64, issn 0022-510XArticle

PC12 cells: a model system for studying drug effects on dopamine synthesis and releaseKITTNER, B; BRÄUTIGAM, M; HERKEN, H et al.Archives internationales de pharmacodynamie et de thérapie. 1987, Vol 286, Num 2, pp 181-194, issn 0003-9780Article

Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synpatosomesBRAUTIGAM, M; KITTNER, B; LASCHINSKI, G et al.Molecular pharmacology. 1985, Vol 28, Num 6, pp 515-520, issn 0026-895XArticle

Clinical trials of propentofylline in vascular dementiaKITTNER, B.Alzheimer disease and associated disorders. 1999, Vol 13, pp 166-171, issn 0893-0341, SUP3Conference Paper

Treatment of patients with elevated plasma levels of low-density lipoproteins with a cholestyramine tablet compared with cholestyramine powderKWITEROVICH, P. O; ZAVORAL, J. H; KAFONEK, S. D et al.Current therapeutic research. 1992, Vol 52, Num 2, pp 330-337, issn 0011-393XArticle

Apomorphine does not decrease tissue levels of tetrahydrobiopterin in vivoBRÄUTIGAM, M; KITTNER, B; HERKEN, H et al.European journal of pharmacology. 1986, Vol 127, Num 1-2, pp 143-146, issn 0014-2999Article

Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's diseaseMIELKE, R; GHAEMI, M; KESSLER, J et al.Journal of the neurological sciences. 1998, Vol 154, Num 1, pp 76-82, issn 0022-510XArticle

Propentofylline in the treatment of vascular dementia and alzheimer-type dementia : Overview of phase I and phase II clinical trialsMIELKE, R; MÖLLER, H.-J; ERKINJUNTTI, T et al.Alzheimer disease and associated disorders. 1998, Vol 12, pp 29-35, issn 0893-0341, SUP2Conference Paper

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-RMARCUSSON, J; ROTHER, M; KITTNER, B et al.Dementia and geriatric cognitive disorders. 1997, Vol 8, Num 5, pp 320-328, issn 1420-8008Article

Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivativesLASCHINSKI, G; KITTNER, B; BRÄUTIGAM, M et al.Naunyn-Schmiedeberg's archives of pharmacology. 1986, Vol 332, Num 4, pp 346-350, issn 0028-1298Article

Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell linesBRÄUTIGAM, M; KITTNER, B; HERKEN, H et al.Arzneimittel-Forschung. 1985, Vol 35, Num 1A, pp 277-284, issn 0004-4172Article